benzamide has been researched along with Breast Neoplasms in 6 studies
benzamide : An aromatic amide that consists of benzene bearing a single carboxamido substituent. The parent of the class of benzamides.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study, we have investigated cytotoxic, apoptosis induction, and molecular docking activities of the spiroquinazolinone benzamide derivatives family on MCF-7 human breast cancer cells." | 7.83 | Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells. ( Arami, S; Balalaei, S; Lavi, MM; Mahdavi, M; Moosavi, MA; Nobarani, M; Rashidi, MR; Yekta, R, 2016) |
| "A serious obstacle to successful treatment of estrogen receptor (ER)-positive human breast cancer is cell resistance to tamoxifen (TAM) therapy." | 7.73 | Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. ( An, P; Appella, E; Clarke, R; Farrar, WL; Huang, J; Inman, JK; Kim, HJ; Osborne, CK; Wang, LH; Yang, XY; Zhang, X, 2006) |
| " In the present study, we have investigated cytotoxic, apoptosis induction, and molecular docking activities of the spiroquinazolinone benzamide derivatives family on MCF-7 human breast cancer cells." | 3.83 | Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells. ( Arami, S; Balalaei, S; Lavi, MM; Mahdavi, M; Moosavi, MA; Nobarani, M; Rashidi, MR; Yekta, R, 2016) |
| "A serious obstacle to successful treatment of estrogen receptor (ER)-positive human breast cancer is cell resistance to tamoxifen (TAM) therapy." | 3.73 | Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer. ( An, P; Appella, E; Clarke, R; Farrar, WL; Huang, J; Inman, JK; Kim, HJ; Osborne, CK; Wang, LH; Yang, XY; Zhang, X, 2006) |
| "Current antiestrogen therapy for breast cancer is limited by the mixed estrogenic and antiestrogenic activity of selective estrogen receptor modulators." | 1.32 | Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor. ( Appella, E; Fan, YX; Farrar, WL; Howard, OM; Maynard, AT; Mihalic, K; Wang, LH; Xiao, W; Yang, XY; Zhang, X, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Androutsopoulos, VP | 1 |
| Spandidos, DA | 1 |
| Mahdavi, M | 1 |
| Lavi, MM | 1 |
| Yekta, R | 1 |
| Moosavi, MA | 1 |
| Nobarani, M | 1 |
| Balalaei, S | 1 |
| Arami, S | 1 |
| Rashidi, MR | 1 |
| Wang, LH | 2 |
| Yang, XY | 2 |
| Zhang, X | 2 |
| Mihalic, K | 1 |
| Fan, YX | 1 |
| Xiao, W | 1 |
| Howard, OM | 1 |
| Appella, E | 2 |
| Maynard, AT | 1 |
| Farrar, WL | 2 |
| Hou, C | 1 |
| Tu, Z | 1 |
| Mach, R | 1 |
| Kung, HF | 1 |
| Kung, MP | 1 |
| An, P | 1 |
| Kim, HJ | 1 |
| Huang, J | 1 |
| Clarke, R | 1 |
| Osborne, CK | 1 |
| Inman, JK | 1 |
| Lin, PH | 1 |
| Lin, CH | 1 |
| Huang, CC | 1 |
| Chuang, MC | 1 |
| Lin, P | 1 |
6 other studies available for benzamide and Breast Neoplasms
| Article | Year |
|---|---|
Antiproliferative effects of TSA, PXD‑101 and MS‑275 in A2780 and MCF7 cells: Acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity.
Topics: Acetylation; Benzamides; Breast Neoplasms; Cell Proliferation; Cell-Free System; Female; Histone Dea | 2017 |
Evaluation of the cytotoxic, apoptosis inducing activity and molecular docking of spiroquinazolinone benzamide derivatives in MCF-7 breast cancer cells.
Topics: Apoptosis; Benzamides; Breast Neoplasms; Cell Cycle; Cell Shape; Cell Survival; DNA Fragmentation; F | 2016 |
Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Base Sequence; Benzamides; Breast Neoplasms; Cell Cycle; | 2004 |
Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker.
Topics: Animals; Benzamides; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Iodi | 2006 |
Disruption of estrogen receptor DNA-binding domain and related intramolecular communication restores tamoxifen sensitivity in resistant breast cancer.
Topics: Animals; Antineoplastic Agents, Hormonal; Benzamides; Binding Sites; Breast Neoplasms; Cell Cycle; C | 2006 |
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.
Topics: Benzamides; Benzoflavones; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Survival; Coumarins; | 2007 |